You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 41 No. 9, September 1984 TABLE OF CONTENTS
  Archives
  •  Online Features
  CLINICAL NOTE
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Herpes Simplex Encephalitis Without CSF Leukocytosis

Nicholas Schlageter, MD; Burk Jubelt, MD; Nicholas A. Vick, MD

Arch Neurol. 1984;41(9):1007-1008.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Herpes simplex encephalitis (HSE) is the most common cause of sporadic acute necrotizing encephalitis in temperate climates.1-3 Untreated, its mortality ranges from 51% to 80% and there is often significant neurologic morbidity among survivors.4,5 Early treatment with vidarabine may reduce mortality to approximately 25%6,7 Herpes simplex encephalitis is diagnosed with a combination of clinical findings, laboratory data such as CSF examination, computed tomographic (CT) scan and EEG, and, now, in a majority of cases, brain biopsy.8 Typical symptoms include acute febrile encephalopathy with headache, alteration of consciousness, behavioral changes, convulsive seizures, dysphasia, and hemiparesis. While no combination of clinical findings definitely distinguishes HSE from other viral encephalitides,9 the occurrence of focal neurologic signs in patients with encephalitis immediately suggests the diagnosis. Focal disruption of the blood-brain barrier as demonstrated by CT or radionuclide brain scanning has been reported to occur early in HSE,10,11 . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Neurology, Northwestern University Medical School, Chicago, and the Division of Neurology, The Evanston (Ill) Hospital.


Footnotes

Accepted for publication Dec 4, 1983.

Reprint requests to Division of Neurology, The Evanston Hospital, 2650 Ridge Ave, Evanston, IL 60201 (Dr Vick).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1984 American Medical Association. All Rights Reserved.